Patients with NAFLD with pronounced intestinal inflammation show decreased numbers of CD4+ and CD8+ T lymphocytes in the intestinal mucosa, associated with increased cytokine secretion and disruption of tight junctions [14]. The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.